Seroprevalence of COVID-19 antibodies
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/028967
- Lead Sponsor
- Kalinga Institute of Medical Sciences KIMS Regional Medical Research Center ICMR Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Relative of patient being included in the study, preferably staying the same household.
2.No known rheumatic diseases
Exclusion Criteria
1.Acquired immunodeficiency syndrome
2.Any active infection as indicated by patient being on systemic antibiotics, anti-fungals or anti-mycobacterial chemotherapy
3.Pregnancy , chronic renal failure , chronic liver disease, diabetes mellitus
4.Any known malignancy or has received chemotherapy in the last six months
5.Patients who have received plasma therapy (for COVID-19)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of antibody levelTimepoint: 4 months (2 months sample collection, 1 month lab analysis, 1 month manuscript preparation)
- Secondary Outcome Measures
Name Time Method ILTimepoint: NA